| Prev Close | 0.00 |
| Day Low/High | 0.00 / 0.00 |
| 52 Wk Low/High | 9.14 / 19.30 |
Osiris To Present Clinical And Scientific Studies At Desert Foot 2016
Experts to host a variety of presentations at Desert Foot Conference, October 19 - 22, 2016, in Phoenix, Arizona
Osiris To Present Clinical And Scientific Studies At Symposium On Advanced Wound Care (SAWC)
Experts to host a variety of presentations at Symposium on Advanced Wound Care, October 07 - 09, 2016, in Las Vegas, Nevada
Osiris Provides Update Regarding NASDAQ Listing Status
Company to Request NASDAQ Hearings Panel to Stay NASDAQ Delisting
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces The Commencement Of An Investigation Into Possible Securities Fraud Violations By Certain Officers And Directors Of Osiris Therapeutics, Inc. -- OSIR
Levi & Korsinsky announces it has commenced an investigation of Osiris Therapeutics, Inc.
MiMedx Goes After Osiris With Lawsuit
The wound care provider filed the suit for allegedly falsifying and misleading consumers with clinical data.
Osiris Provides Update Regarding NASDAQ Listing Matters
Osiris Therapeutics, Inc. (NASDAQ:OSIR) (the "Company"), today provided an update regarding the status of its compliance with the Listing Rules of the NASDAQ Stock Market ("NASDAQ").
Osiris To Present At The 26th European Wound Management Association Conference
Osiris Therapeutics, Inc. (NASDAQ: OSIR), the leading cellular regenerative medicine company focused on developing and marketing products to treat conditions in wound care, orthopaedics and sports medicine, will present...
Osiris Therapeutics Enters Oversold Territory (OSIR)
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.
Grafix Demonstrates Superior Clinical Outcomes Compared With EpiFix In "Real World" Study
Osiris Therapeutics, Inc. (NASDAQ: OSIR), a leading cellular and regenerative medicine company, focused on developing and marketing products to treat conditions in wound care, orthopaedics and sports medicine,...
Osiris To Present 15 Advanced Clinical And Scientific Abstracts
Osiris Therapeutics, Inc. (NASDAQ:OSIR), the leading cellular regenerative medicine company focused on developing and marketing products to treat conditions in wound care, orthopaedics and sports medicine, will present...
Osiris Announces Further Expansion Of Grafix Commercial Coverage
Osiris Therapeutics, Inc. (NASDAQ: OSIR), a leading cellular and regenerative medicine company focused on developing and marketing products to treat conditions in wound care, orthopaedics and sports medicine,...
Osiris Therapeutics Stock Sees Short Interest Fall 19%
The most recent short interest data has been released by the NASDAQ for the 03/15/2016 settlement date, which shows a 896,133 share decrease in total short interest for Osiris Therapeutics Inc , to 3,829,449, a decrease of 18.96% since 02/29/2016. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.
Osiris Therapeutics Announces Receipt Of Deficiency Letter From NASDAQ
Osiris Therapeutics, Inc. (NASDAQ: OSIR), a leading cellular and regenerative medicine company focused on developing and marketing products to treat conditions in wound care, orthopaedics and sports medicine,...
Osiris Therapeutics To Present At The 4th Annual Cell And Gene Therapy Investor Day
Osiris Therapeutics, Inc. (NASDAQ: OSIR), a leading cellular and regenerative medicine company focused on developing and marketing products to treat conditions in wound care, orthopaedics and sports medicine,...
Osiris Provides An Update On A Clinical Review By Blue Cross Blue Shield Association
Osiris Therapeutics, Inc. (NASDAQ: OSIR), a leading cellular and regenerative medicine company focused on developing and marketing products to treat conditions in wound care, orthopaedics and sports medicine,...
Relative Strength Alert For Osiris Therapeutics
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.
First Week of March 18th Options Trading For Osiris Therapeutics (OSIR)
Investors in Osiris Therapeutics Inc saw new options become available this week, for the March 18th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the OSIR options chain for the new March 18th contracts and identified the following call contract of particular interest.
Grafix Demonstrates Positive Clinical Outcomes In Chronic Complex Wounds With Exposed Tendon And Bone
Osiris Therapeutics, Inc. (NASDAQ: OSIR), a leading cellular and regenerative medicine company focused on developing and marketing products to treat conditions in wound care, orthopaedics and sports medicine,...
Osiris Confirms Dwayne Montgomery, As President And Chief Executive Officer, And The Election Of Thomas M. Brandt To The Board Of Directors
Osiris Therapeutics, Inc. (NASDAQ: OSIR), a leading cellular and regenerative medicine company focused on developing and marketing products to treat conditions in wound care, orthopaedics and sports medicine, is...